Skip to main content
SpringerLink
Log in

Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland

  • Original Article
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Introduction

Prostate cancer is the most common solid cancer affecting men in Ireland. Transrectal ultrasound (TRUS) biopsies of the prostate are routinely performed to diagnose prostate cancer. They are, in general, a safe procedure but are associated with a significant risk of infective complications ranging from fever, urinary tract infection to severe urosepsis. At present, there are no recommended national guidelines on the use of antibiotic prophylaxis to minimise the risk of infective complications post-TRUS biopsy.

Aim

To review the antibiotic prophylaxis for TRUS biopsy used in Irish hospitals.

Method

We used a standard telephone questionnaire to establish what antibiotic protocol is in use in each hospital.

Results

40 hospitals were contacted, of which 29 perform TRUS biopsies. In the majority of hospitals, TRUS biopsies are carried out in the radiology department. All hospitals administer antibiotic prophylaxis but there is wide variation in the protocols used. There are five different antibiotics prescribed, ciprofloxacin being the most common. Treatment protocols vary from 1 to 10 days antibiotic cover post procedure.

Conclusion

There is a lack of standardisation of antibiotic prophylaxis in Irish hospitals. There is a need for guidelines to clarify the most appropriate antibiotic, route of administration and duration of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sakr W, Grignon DJ, Crissman JD (1994) High grade prostatic intraepithelial neoplasia in (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases. In Vivo 8:439–443

    PubMed  CAS  Google Scholar 

  2. Cancer in Ireland (2011) Annual report of the National Cancer Registry Ireland. http://www.ncri.ie

  3. Enlund A, Varenhorst E (1997) Morbidity of ultrasound core biopsy of the prostate without antibiotic therapy. Br J Urol 79(5):777–780

    Article  PubMed  CAS  Google Scholar 

  4. Tal R, Livne PM, Lask DM, Baniel J (2003) Empirical management of urinary tract infection complicating transrectal ultrasound guided prostate biopsy. J Urol 169(5):1762–1765

    Article  PubMed  Google Scholar 

  5. Shandera KC, Thibault GP, Deshon GE Jr (1998) Variability in patient preparation for prostate biopsy among American urologists. Urology 52(4):644–646

    Article  PubMed  CAS  Google Scholar 

  6. Roach M, Figuero TE, McBride D, George WJ, Neal DE Jr (1991) Ciprofloxacin versus gentamycin against bacteremia in transrectal prostate needle biopsy. Urology 38(1):84–87

    Article  PubMed  CAS  Google Scholar 

  7. Feliciano J, Teper E, Ferrandino M et al (2008) The incidence of fluoroquinolone resistant infections after prostate biopsy—are fluoroquinolones still effective? J Urol 179:952–955

    Article  PubMed  Google Scholar 

  8. Cannon GJ, Smaldone MC, Paterson DL (2007) Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis. Can J Urol 14(4):3653–3655

    PubMed  Google Scholar 

  9. Liss M, Peeples AN, Peterson EM (2011) Detection of fluoroquinolone resistant organisms from rectal swabs using selective media prior to a transrectal prostate biopsy. J Clin Microbiol 49(3):1116–1118

    Google Scholar 

  10. Gagliotti C, Nobilio L, Moro ML (2007) Emilia-Romagna antibiotic resistance study group, emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples. Clin Microbiol Infect 13(3):328–331

    Article  PubMed  CAS  Google Scholar 

  11. Batura D, Rao GG, Bo Nielsen P, Charlett A (2010) Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates. BJU Int

  12. Carey J, Korman HJ (2001) Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol 166(1):82–85

    Article  PubMed  CAS  Google Scholar 

  13. Kim S, Kim SI, Ahn HS, Choi JB, Kim YS, Kim SJ (2010) Risk factors for acute prostatitis after transrectal biopsy of the prostate. Korean J Urol 51(6):426–430

    Article  PubMed  Google Scholar 

  14. Briffaux R, Coloby P, Bruyere F, Ouaki F et al (2009) One preoperative dose randomised against a 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy. BJU Int 103(8):1069–1073

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, St. Vincent’s University Hospital, Elm Park, Dublin 4, Ireland

    L. G. Smyth & D. W. Mulvin

Authors
  1. L. G. Smyth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. W. Mulvin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. G. Smyth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smyth, L.G., Mulvin, D.W. Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland. Ir J Med Sci 181, 33–35 (2012). https://doi.org/10.1007/s11845-011-0774-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-011-0774-5

Keywords

Search

Navigation